Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0024 | 0 | 0.5 |
Entamoeba histolytica | Niemann-Pick C1 protein, putative | 0.0099 | 0.1122 | 1 |
Echinococcus granulosus | carnitine O palmitoyltransferase 2 | 0.0059 | 0.0532 | 0.0261 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0 | 0.5 |
Echinococcus multilocularis | expressed conserved protein | 0.0093 | 0.1032 | 0.0775 |
Loa Loa (eye worm) | hypothetical protein | 0.0237 | 0.3193 | 0.3274 |
Schistosoma mansoni | choline o-acyltransferase | 0.0059 | 0.0532 | 0.0284 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0693 | 1 | 1 |
Trypanosoma brucei | carnitine O-palmitoyltransferase II, putative | 0.0059 | 0.0532 | 0.5 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0042 | 0.0278 | 0.0285 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 2 | 0.0059 | 0.0532 | 0.0261 |
Echinococcus granulosus | expressed conserved protein | 0.0093 | 0.1032 | 0.0775 |
Brugia malayi | Choline O-acetyltransferase | 0.0059 | 0.0532 | 0.0546 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.1122 | 0.115 |
Onchocerca volvulus | 0.0048 | 0.0368 | 0.6912 | |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0024 | 0 | 0.5 |
Trypanosoma brucei | carnitine O-palmitoyltransferase, putative | 0.0059 | 0.0532 | 0.5 |
Echinococcus granulosus | carnitine O palmitoyltransferase 1 liver | 0.0324 | 0.4487 | 0.4329 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0237 | 0.3193 | 0.2998 |
Leishmania major | carnitine palmitoyltransferase-like protein | 0.0059 | 0.0532 | 0.1187 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0278 | 0.0285 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0024 | 0 | 0.5 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0024 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0024 | 0 | 0.5 |
Loa Loa (eye worm) | carnitine O-palmitoyltransferase I isoform | 0.0059 | 0.0532 | 0.0546 |
Onchocerca volvulus | 0.0059 | 0.0532 | 1 | |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0141 | 0.1756 | 0.152 |
Brugia malayi | hypothetical protein | 0.0237 | 0.3193 | 0.3274 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0024 | 0 | 0.5 |
Onchocerca volvulus | 0.0059 | 0.0532 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.0532 | 0.0546 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0059 | 0.0532 | 0.0546 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0042 | 0.0278 | 0.5 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 1, liver | 0.0324 | 0.4487 | 0.4329 |
Trypanosoma brucei | carnitine O-acetyltransferase, putative | 0.0059 | 0.0532 | 0.5 |
Schistosoma mansoni | choline o-acyltransferase | 0.0059 | 0.0532 | 0.0284 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0059 | 0.0532 | 0.5 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0 | 0.5 |
Loa Loa (eye worm) | choline O-acetyltransferase | 0.0059 | 0.0532 | 0.0546 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0 | 0.5 |
Brugia malayi | CHE-14 protein | 0.0042 | 0.0278 | 0.0285 |
Brugia malayi | Choline O-acetyltransferase | 0.0059 | 0.0532 | 0.0546 |
Onchocerca volvulus | 0.0059 | 0.0532 | 1 | |
Echinococcus granulosus | choline O acetyltransferase | 0.0059 | 0.0532 | 0.0261 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0676 | 0.9752 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0676 | 0.9752 | 1 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0693 | 1 | 1 |
Schistosoma mansoni | patched 1 | 0.0042 | 0.0278 | 0.0023 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0324 | 0.4487 | 1 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0141 | 0.1756 | 0.152 |
Leishmania major | choline/Carnitine o-acyltransferase-like protein | 0.0324 | 0.4487 | 1 |
Echinococcus multilocularis | protein dispatched 1 | 0.0048 | 0.0368 | 0.0092 |
Echinococcus multilocularis | choline O acetyltransferase | 0.0059 | 0.0532 | 0.0261 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.01 | 0.1145 | 0.0912 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0324 | 0.4487 | 1 |
Leishmania major | carnitine/choline acetyltransferase, putative | 0.0059 | 0.0532 | 0.1187 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0099 | 0.1122 | 0.0868 |
Schistosoma mansoni | survival motor neuron protein | 0.0048 | 0.0368 | 0.0116 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0048 | 0.0368 | 0.0377 |
Onchocerca volvulus | 0.0059 | 0.0532 | 1 | |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0059 | 0.0532 | 0.0546 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0368 | 0.0116 |
Mycobacterium ulcerans | hypothetical protein | 0.0024 | 0 | 0.5 |
Trypanosoma brucei | carnitine O-palmitoyltransferase II, putative | 0.0059 | 0.0532 | 0.5 |
Brugia malayi | Niemann-Pick C1 protein precursor | 0.0099 | 0.1122 | 0.115 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0421 | 0.0432 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0237 | 0.3193 | 0.2998 |
Loa Loa (eye worm) | choline/Carnitine O-acyltransferase | 0.0059 | 0.0532 | 0.0546 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0099 | 0.1122 | 0.0868 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.